dj Orthopedics closes Aircast acquisition
This article was originally published in The Gray Sheet
dj Orthopedics CEO Les Cross sees the $290 mil. deal, closed April 7, leading to an additional $15 mil.-$20 mil. for the firm in 2007. dj Ortho-pedics plans to completely integrate Aircast infrastructure by the end of 2006 (1"The Gray Sheet" April 10, 2006, p. 7)...
You may also be interested in...
St. Jude Medical's stock ended the 2006 first quarter down 18% to $41 per share following CMS' decision to reimburse a device that can identify patients who are unlikely to benefit from an implantable cardioverter defibrillator, St. Jude's bread and butter
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.